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(2).  At the University of Alberta, 21% of students have
reported at least one unwanted sexual experience (3).
Sexual assault is widespread and occurs with alarming
frequency.  
Recovery from sexual- assault- related Posttraumatic
Stress Disorder (PTSD) is not solely measured by
eliminating symptoms or achieving specific outcomes.
Healing from this trauma does not mean that the
survivor will forget the experience or never again
experience any symptoms. Rather, successful recovery
is subjective and measured by whether the survivor
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ABSTRACT: Sexual assault occurs with alarming frequency in Canada.  The prevalence of
Posttraumatic Stress Disorder (PTSD) in assault survivors is drastically higher than the national
prevalence of the disorder, which is a strong indication that the current therapies for sexual-
assault-related PTSD are in need of improvement.  Increasing knowledge and understanding of the
pathologies associated with rape trauma in biological, psychological and sociological domains will
help to develop more effective treatments for survivors.  A dysregulation of the Hypothalamic-
Pituitary-Adrenal (HPA) axis is observed in survivors of sexual assault and this may be a
fundamental cause of the structural and functional abnormalities contributing to PTSD symptoms.
Pharmacotherapies are available to treat PTSD; however, they are often inadequate or unwanted
by the survivor. Psychological health is compromised following interpersonal trauma and many
psychological therapies are available, but with varying efficacy.  A person's cognitions have a
dramatic effect on the onset, severity, and progress of PTSD following sexual assault.  Sociological
impacts of assault influence the development of PTSD through victim-blaming attitudes and the
perpetuation of rape myths.  Perceived positive regard and early social support is shown to be
important to successful recovery.  Education is vital in rape prevention and to foster a supportive
environment for survivors.  The biological, psychological and sociological impacts and treatments
should not remain mutually exclusive. A better appreciation of the biopsychosocial repercussions
of sexual assault will aid in developing a more holistic and individualized therapy to help alleviate
the physical and emotional pain following the trauma of rape.
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INTRODUCTION
One woman is sexually assaulted in Canada every
minute (1).  Sexual assault is any form of sexual contact
without voluntary consent andthat violates a person's
sense of autonomy, control and mastery over their body112
increases his or her involvement in the present, acquires
skills and attitudes to regain control of his of her life,
forgive him or herself for guilt, shame and other
negative cognitions, and gain stress reduction skills for
overall better functioning (4).  There are many factors
involved in successful recovery, including the degree of
support received, previous self-concept, personal
strength, and professional treatment provided by the
medical and justice systems (5).  PTSD is one of the
problems that may result from failure of the recovery
process.  
PTSD is caused by exposure to a traumatic event and
intense psychological distress occurs as a result of re-
experiencing the event (6).  PTSD is diagnosed when
symptoms last longer than one month (7).  To prevent
the distressing reactions, survivors will avoid stimuli
that provoke these feelings and this avoidance
behaviour can be severe enough to significantly impair
daily life (8).
The consequences of a sexual assault may be
manifested biologically, psychologically, and
sociologically.  By gaining a better appreciation of the
repercussions of sexual assault, a holistic and
individualized therapy can be developed to ameliorate
the physical and emotional pain following the trauma.
The issues facing individuals who have experienced
sexual assault will be discussed and improvements in
current treatments will be suggested, with hopes to
develop more effective and holistic therapies in the
future.
POSTTRAUMATIC STRESS DISORDER
The US National Comorbidity Survey Report
estimates the lifetime prevalence of PTSD among North
Americans to be 7.8% (9).  The lifetime prevalence of
PTSD for women who have been sexually assaulted is
50% (10).  Moreover, sexual assault is the most frequent
cause of PTSD in women, with one study reporting that
94% of women experienced PTSD symptoms during
the first two weeks after an assault (9).  
The alarmingly high rate of PTSD in survivors of
sexual assault is a strong indication that the current
therapies for rape victims are inadequate and in need of
improvement.  There is no 'cookie cutter' treatment for
every victim suffering with PTSD, as the disorder can
manifest itself in many ways (8).  It is important to
consider the biological, psychological, and sociological
impacts when developing effective treatment and
intervention methods for sexual-assault-related PTSD.
PTSD PATHOPHYSIOLOGY 
Before treatment for sexual-assault-related PTSD can
be developed, an understanding of the pathophysiology
of PTSD is critical. The dysregulation seen in
individuals with PTSD can be observed and measured
on all major systems of the body including the neural,
endocrine and immune systems (6).  The Hypothalamic-
Pituitary-Adrenal (HPA) axis plays a key regulatory
function in the body, controlling all three systems
through negative feedback inhibition. Cortisol is a
major hormone of the HPA axis and is the primary stress
hormone in the body.  It is released when stimulated by
Corticotropin Releasing Hormone (CRH) and inhibited
via negative feedback acting at the hypothalamic and
pituitary levels. Intense psychological trauma such as
sexual abuse can cause changes in the body's response
to stress by increasing levels of CRH and dysregulating
the HPA axis (11, 12).  This results in a decreased
number of CRH receptors in the anterior pituitary,
decreased pituitary responsiveness to CRH, and
disturbed negative feedback inhibition (13).  Reduced
responsiveness to CRH causes overactivation of the
HPA axis and can disturb negative feedback by cortisol
(Figure 1).  Cortisol has widespread action and its
dysregulation affects other neural systems including the
mesocorticolimbic dopaminergic system, leading to
inappropriate fear reactions and persistent mild
depression (14).  
PHARMACOTHERAPY TREATMENT OPTIONS
FOR PTSD
Knowledge of the biological changes with PTSD has
led to the development of new treatments that offer
more comprehensive management of PTSD and enable
patients to enjoy an improved quality of life (11).  For
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Figure 1. The hypothalamic-pituitary-adrenal axis 
The HPA axis is dysregulated in survivors of sexual assault.  A
reduced responsiveness to CRH is observed and the negative
feedback by cortisol on the hypothalamus and pituitary is disturbed.
[Retrieved April 9th, 2006 from
http://www.montana.edu/wwwai/imsd/alcohol/Vanessa/vwhpa_files/i
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example, various drug treatments have been developed
to treat PTSD.  There are five main goals for treating
PTSD with medications, including a reduction of the
core symptoms such as anxiety and flashbacks, an
improvement in stress resilience, an improvement in the
quality of life, and a reduction in disability and
comorbidity (15).  As Brunello et al. notes, it is
important to maintain wellness and prevent relapse (6).
Concurrent with HPA axis dysfunction, disruption of
glutamatergic, serotonergic, and adrenergic systems is a
fundamental cause of the structural and functional
abnormalities which contribute to the symptoms of
PTSD.  Such symptoms include hyperarousal and re-
experiencing feelings associated with the trauma
through flashbacks or nightmares (11).  The persistent
re-experiencing of traumatic events may cause an
increase in CRH levels, which damages the
hippocampus, an important region of the brain
associated with learning and memory (16, 17).  With
psychological trauma, a decrease in hippocampal
volume has been observed (6).  This volume decrease,
when coupled with hypersensitivity of the HPA axis, is
associated with a reduction of cognitive functioning
drastically affecting the performance of affected
individuals (18).  Selective Serotonin Reuptake
Inhibitors (SSRIs) have been successfully used to treat
these hyperarousal symptoms purported to be caused by
a decrease in hippocampal volume. SSRIs are
commonly used to treat depression and there is some
evidence that they may promote neurogenesis, which
might be the therapeutic mechanism by which these
medications effect changes in behaviour (18).  For
example, Bremner and Vermetten demonstrated a 4.6%
increase in the volume of the hippocampus and an
improvement in memory of PTSD patients through
treatment with the SSRI Paroxetine (18).  
Many hormones and receptors in the glutamatergic,
serotonergic, and adrenergic systems have been
identified as key factors in memory and perception, one
of which is the gamma-aminobutyric acid receptor
(GABA-R) (11). Following sexual abuse and the
development of PTSD, the dysregulation of the HPA
axis can stimulate the adrenergic system, activating
GABA-R (15).  The multifaceted interactions between
these systems may explain the connections of emotions
with factual memory.  It has been proposed that while a
traumatic memory is re-lived during a flashback, there
is an increase in the stimulation of GABA-R caused by
an increase in the release of endogenous
benzodiazepines (15).  To control the overstimulation of
GABA-R and thereby control anxiety and flashbacks,
benzodiazepine inhibitors such as flumazenil have been
used successfully (11). This has also been achieved with
clonidine to stop nightmares by decreasing the release
of catecholamines, a key component of the anxiety-
provoking 'fight or flight' response of the autonomic
nervous system (19).
The immune system is reciprocally regulated by the
neural and endocrine systems and can also be affected
by PTSD (20). PTSD often co-occurs with various
inflammatory diseases, likely due to HPA axis
dysregulation affecting the immune system (21).
Immunomodulation is therefore important to avoid this
subsequent dysregulation of the immune system and
this can be achieved with SSRIs such as Fluvoxamine.   
Fluvoxamine has been shown to be effective in
decreasing the hyperresponsiveness of the HPA axis,
thereby increasing levels of interleukins and other
essential immune factors (22). Interestingly, there is a
sexual dimorphism in immune functioning, as men with
PTSD were found to have an inhibited cell-mediated
immunity, while women showed enhanced cell-
mediated immunity (21).  A better understanding of this
is necessary and it is important to consider sexual
dimorphism for immunomodulation. 
Other drug treatment options are available for PTSD
including Tricyclic Antidepressants (TCA), Monoamine
Oxidase Inhibitors (MAOI), SSRIs, serotonin
antagonists, and anticonvulsants and are described in
Table 1 (23).  Although there are some promising
studies for medications, reviews of pharmacotherapies
for PTSD have revealed that most treatments are
inadequate, aside from some supportive evidence of
SSRI effectiveness (24).  Therefore it is useful to look
towards other disciplines for additional treatment.  
PSYCHOLOGY OF PTSD AND COGNITIVE
FACTORS 
Although the pathology associated with PTSD has a
biological basis, the treatment need not be restricted to
drugs.  For example, a serious consequence of HPA axis
dysregulation is the effect on the steroid hormones,
namely estrogen and testosterone, which are also
modulated through this axis (25).  As a result, some
survivors of sexual assault can become infertile due to
sex steroid dysregulation.  Interestingly, research
indicates that fertility may be restored with cognitive
behavioural therapy (CBT), just one example of many
where psychological intervention was used to treat a
biologically based malady (26). 
After an assault, survivors experience The Rape
Trauma Syndrome (RTS), which affects not only
victims of rape, but also victims of all types of sexual
violence and would perhaps be better labelled as Sexual
Assault Trauma Syndrome.  RTS is characterized by
three phases (27).  The Acute Phase occurs immediately
following the assault when the survivor is in crisis and
experiences a wide range of emotional reactions.  These
2006114
reactions may be categorized as Expressive, such as
shaking, crying or yelling; or Controlled such as
flattened affect, appearing outwardly calm and subdued.
The second phase is Outward Adjustment, when the
survivor focuses less on the assault, often with a high
level of denial, and involves themselves in normal daily
activities.  The final phase is Long Term
Reorganization, in which the survivor integrates the
assault into their view of themselves and resolves their
feelings about the assailant.  There are many
psychological effects to consider following a sexual
assault such as feelings of shame, guilt, anxiety or
depression (9).  These feelings may be even stronger
and more harmful if the survivor does not receive
support from their family, friends or authorities (9).  
Cognitive factors play a large role in the onset,
severity, and outcome of PTSD after sexual assault (28).
These factors include mental defeat and confusion,
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Table 1. Summary of pharmacologic treatment options for PTSD
Drug classification Drug Name   Effects on PTSD improvement  
Tricyclic antidepressants Amitryptiline - 50% of treated patients had a final CGI-I1 score of 1 or 2 ("very 
much" or "much improved") as compared to 17% for placebo
Imipramine - 25% decrease from baseline in IES2 scores for treated patients as compared
to 5% for placebo
- 65% of treated patients were found to improve on a Global Scale as 
compared to 28% for placebo
Monoamine Oxidase  Phenelzine -  45% decrease from baseline in IES score as compared to 5% for placebo
Inhibitors
Brofaromine - Reductions in PTSD symptoms were reported, however no difference was 
found between treatment group and placebo group
Moclobemide - 11 of 20 participants no longer met the criteria for PTSD at the end of a 12 
week trial
Selective Serotonin  Fluoxetine - 85% of treated patients showed improvement on a Global Rating Scale as 
Reuptake Inhibitors compared to 62% of patients taking placebo
- Response rate on High End State Functioning was 41% for treatment group
and 4% for placebo
Sertraline - 43% decrease in CAPS3 score for treatment group as compared to 31% for
placebo
- 39% decrease in DTS4 score for treatment group as compared to 24% for 
placebo 
Paroxetine - 50% decrease in DTS score for treatment group
- 40% decrease in IES score for treatment group
Fluvoxamine - 64% of patients had a Duke Improvement score or 1 or 2
- Significant reductions in mean scores for all efficacy scales used (TOP-85, 
DTS, IES) 
5-HT2 Antagonist Nefazodone - A decrease in PTSD severity on a Primary Assessment Scale in both combat
veterans and civilians was observed
Anticonvulsants Lamotrigine - 50% of patients in treatment group responded as compared to 25% for 
placebo group*
Carbamazepine - 70% of patients had a response of "moderate" or "very much" improvement
Valproate - Approximately 70% of patients had a response of "moderate" or "very 
much" improvement
1. Clinical Global Impressions-Improvement Scale
2. Impact of Events Scale
3. Clinician Administered PTSD Scale
4. Davidson Trauma Scale
5. 8-Item Treatment-Outcome PTSD Scale115 McGill Journal of Medicine 2006
negative appraisal of emotions and symptoms,
avoidance and perceived negative responses from
others (5).  If the survivor of sexual assault believes that
others have failed to react in a positive and supportive
manner, there is a greater risk of PTSD (9).  It has been
suggested that trauma recovery is characterized by a
reprogramming, integration, and habituation to the
traumatic images, leading to a restoration of a sense of
safety (29).  Over time, PTSD symptoms will decrease,
the survivor will be less preoccupied with blame
towards self and others, and a will achieve a regained
sense of control (29). 
Events perceived as uncontrollable are much more
distressing than controllable events, therefore with
uncontrollable events such as sexual assault, survivors
will attempt to attribute blame to behavioural,
dispositional or vicarious causes (30).  Behavioural self-
blame has the potential to be adaptive as it promotes the
belief that negative outcomes can be avoided in the
future; whereas dispositional self-blame attributes the
traumatic event to one's personality and this thinking
does not give a sense of future control (30).  Vicarious
control refers to the perception that some other person
or entity had control over the occurrence of that event
(30). Attributing blame in any of these ways focuses on
the past and is associated with poorer outcomes in
PTSD.  To improve PTSD, treatment outcomes
emphasis should be on controlling the present situation
and what can be done about the impact of the event,
rather than how it could have been avoided or can be
avoided in the future (30).  In view of the fact that
control over the recovery process results in lowered
distress levels, fostering this form of control could be an
important component of interventions for sexual assault
survivors (30).  
Early intervention is critical for sexual assault victims
because the level of distress immediately following the
assault is strongly correlated to future pathologies and
PTSD (31).  In a study collecting self-reports from
survivors of assault that assessed their degree of support
and psychological distress during and immediately
following the rape, it was found that high distress levels
significantly predicted increased levels of fear and
anxiety in the months following the assault (31).  As the
level of distress is strongly correlated to PTSD
symptoms, an attempt to decrease levels of distress
immediately following sexual assault may result in a
more positive treatment outcome.  When survivors seek
medical assistance, the forensic rape exam can be very
traumatizing (32). Resnick et al., demonstrated that
meeting with a rape crisis counsellor or viewing a video
before a forensic rape exam depicting in detail what to
expect during the exam, resulted in decreased levels of
stress after the exam in test groups compared to the non-
video control group (32).  Of all the eligible women,
81% agreed to participate in this video study, indicating
that this is a feasible way to decrease distress and reduce
future PTSD development following the physical
examination.
Since November 1999, the Edmonton Capital Health
Authority has run the Sexual Assault Response Team of
Edmonton (SARTE) (33).  This form of intervention has
been very effective in lowering levels of distress in the
hospital setting.  SARTE consists of a team of nurses
who are sensitized to the particular needs of survivors,
and specialized in dealing with victims of sexual
assault.  When working with survivors, the nurses
explain in detail the procedures they will perform, assist
patients in reporting to the police, and maintaining an
open environment where the survivor is able to make as
many decisions on their own as possible (28). 
PSYCHOTHERAPY TREATMENT OPTIONS
FOR PTSD
In addition to promising social programs, there are
many therapies focussing on the psychological aspect of
PTSD. CBT focuses on changing thought patterns and
cognitions to decrease negative emotions, develop skills
to cope with anxiety and negative thoughts, restore
effective social skills, and develop ways to manage
anger and future trauma symptoms (9). 
Eye Movement Desensitization and Reprocessing
(EMDR) is an Information Processing Therapy that
combines elements of CBT, psychodynamic,
interpersonal, experiential and body-centred therapies
to treat PTSD (34).  During EMDR, the client thinks of
past or present traumatic experiences while
concurrently focusing on a stimulus such as auditory
tones, tactile stimulation, or visual cues (34).  This leads
to dual attention, changing the processing of the
traumatic memories and decreasing anxiety when
thinking about the traumatic experience.  It has been
suggested that PTSD is due to an inability to adequately
process the trauma and EMDR may be useful in this
reprocessing (35).  In an EMDR study by Rothbaum,
only 10% of participants who were treated with EMDR
therapy exhibited PTSD symptoms after treatment,
compared to 88% of non-treatment control patients
(36).  Although the role of the eye movements has been
contested, EMDR is proving to be an effective
treatment option for PTSD (36).  
Group therapy can be very effective to help survivors
focus on the present and share experiences with others
in a safe and empathetic environment.  According to one
survey, over half of the women who experienced sexual
assault within the previous five years never told anyone
about their trauma (37).  This silence can have an
important impact on the development of PTSD, as the116 Sexaul Assault and Posttraumatic Stress Disorder Vol. 9  No. 2
degree of support received can influence symptom
severity (5).  Individuals who receive bad or no support
report more PTSD symptoms (28).
Psychodynamic therapy focuses on the emotional
conflicts caused by the trauma, especially as they
pertain to early life experiences.  This helps to develop
self-esteem, effective ways of thinking and coping, and
may be used to treat PTSD (9).  As discussed earlier,
focusing on the past is associated with poorer
adjustment and present control should be encouraged
(30).  As such, psychodynamic therapy may be less
effective than other therapies for assault victims.
New psychological therapies and treatments are
continually developed as older ones are re-evaluated.
For example, trauma debriefing is common practice to
reduce distress and aid in recovery immediately
following a traumatic experience.  Recently, it has been
found that debriefing did not prevent the onset of PTSD
and may even increase the risk of PTSD symptoms,
demonstrating that treatments should be continuously
evaluated and modified (38). 
Both pharmacotherapy and CBT are viable treatment
options for PTSD, however it is clear that empowering
victims by giving back control is crucial in successful
recovery.  In one study, survivors were asked to choose
between CBT with prolonged exposure to traumatic
stimuli or the SSRI medication Sertraline (39).
Participants of the study rated CBT as more credible
and had more positive feelings towards this treatment
option, citing effectiveness and potential side effects as
the two primary factors in their decision.  When
presenting treatment options, it is important to explain
both options and put side effects in perspective.  Many
women do not want pharmacotherapy and the therapy
provider should give victims of assault a choice when
deciding treatment options, to help them regain a sense
of control (39).  
SOCIOLOGICAL ISSUES CONTRIBUTING TO
PTSD
Recovery from psychological issues due to sexual
assault related PTSD is not solely an individual
challenge, but also a challenge for those close to the
affected individual (27).  The recovery process is also a
sociological issue and societal aspects should not be
ignored.  Research indicates that initial levels of distress
and perceived control are key factors in the onset and
severity of PTSD (31).  Perceived positive regard and
support has also been shown to be important to recovery
(28).  Less than half of individuals who have been
sexually assaulted disclose the assault to others and it is
clear that many are not getting the support they require.
As a large part of the recovery process is related to a
solid support network, part of the discussion of
treatment and prevention of PTSD should be
sociologically directed by targeting attitudes towards
and origins of sexual assault with considerations of how
these attitudes may create a rape-prone society and
allow for such a high frequency of sexual assault.  
There are many rape myths in our society, for
example, beliefs that individuals lie about being
assaulted, perpetrators are easily identifiable, or that
men cannot be sexually assaulted.  These myths
promote negative attitudes and victim-blaming
philosophies.  Education is the first step in preventing
PTSD associated with assault.  The number of sexual
assault victims willing to tell someone about their
experience is increasing, potentially because there is
less of a stigma attached to it today and there are more
voluntary and professional support agencies (37).
Although this shows some improvement, many
individuals still have attitudes that sex role stereotyping,
adversarial sexual beliefs, and acceptance of
interpersonal violence, all of which lead to greater
acceptance of rape myths (40).  Although sexual assault
programs are becoming more pervasive across college
campuses, these programs are not always effective in
implementing meaningful changes in cognition and
behaviour (32).  By understanding the failures of
education programs, directions for improvement are
found.  Increasing program length may allow for more
meaningful changes in cognition and behaviours to
occur (41).  Targeting the attitudes that lead to greater
acceptance of rape myths may lead to a more supportive
community for victims of sexual assault.  Education is
vital in rape prevention and to foster a supportive
environment for survivors of this crime, but it is clear
that more research is needed to improve the efficacy of
these programs.  
Many survivors who disclose their assault to others
experience secondary victimization.  Secondary trauma
occurs when survivors seek assistance from medical,
legal or healthcare professionals, but these professionals
often exhibit and use victim-blaming behaviours (42).
Contact with many services especially those which do
not specialize in sexual assault traumatization, can
increase survivors' psychological and physical distress
(43).  
Society contributes to the acceptance of rape myths
through individuals the survivor solicits for help as well
as by contributing to the negative cognitions of the
survivors themselves.  Negative cognitions foster self-
blame and increase the risk of post-assault
psychopathologies, likely contributing to the low
disclosure rates. 
CONCLUSION
Recovery from rape trauma is a deeply personal and117 McGill Journal of Medicine 2006
highly individualized journey. As knowledge of the
pathophysiology of PTSD improves, more effective
medications are developed to treat and manage the
biological aspects of this disorder.  Psychological
therapies are available to assist survivors in their
recovery.  The number of rape prevention centres and
education programs are on the rise with aims to debunk
rape myths, change victim-blaming attitudes and de-
stigmatize the subject. One of the most important
aspects in assisting the recovery process is empowering
the survivor and putting control back into their hands.
The three-treatment modalities for the biological,
psychological, and sociological impacts should not
remain mutually exclusive.  Physicians, therapists, law
enforcement agencies, and family and friends must
work together to find the meaning of recovery from the
perspective of the survivors and to understand what
conditions will facilitate growth and recovery.  When
the therapies available to treat sexual-assault-related
PTSD are brought together during the right stages in the
recovery process to form a comprehensive treatment of
the highly individual survivor, greater success in
decreasing the rate of PTSD associated with sexual
assault may be achieved. 
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